Yield10 Bioscience Settles Convertible Note Early for $500K
Company Announcements

Yield10 Bioscience Settles Convertible Note Early for $500K

An announcement from Yield10 Bioscience (YTEN) is now available.

Yield10 Bioscience, Inc. and MPC Investment LLC have mutually agreed to terminate a $1 million senior unsecured convertible note, with an 8% annual interest rate, ahead of its maturity date. Instead of the full amount plus interest, totaling over $1.1 million, a settlement of $500,000 was made by the company to fully satisfy the obligations of the note, marking the end of their financial agreement.

For a thorough assessment of YTEN stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyYield10 Bioscience grants Nufarm a commercial license to Omega-3 assets
TheFlyYield10 Bioscience granted exclusive license from Rothamsted Research
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!